A multi-centric randomized phase II trial evaluating dual targeting of the EGFR with cetuximab and afatinib versus cetuximab alone in patients with chemotherapy refractory wtKRAS metastatic colorectal cancer (UCGI 25: A UNICANCER trial).

Affiliation auteurs!!!! Error affiliation !!!!
TitreA multi-centric randomized phase II trial evaluating dual targeting of the EGFR with cetuximab and afatinib versus cetuximab alone in patients with chemotherapy refractory wtKRAS metastatic colorectal cancer (UCGI 25: A UNICANCER trial).
Type de publicationJournal Article
Year of Publication2016
AuteursSenellart H, Samalin E, Castan F, Borg C, Adenis A, de la Fouchardiere C, Malka D, Guerin-Meyer V, Francois E, Ben Abdelghani M, Boucher E, Andre T, Ghiringhelli F, Lievre A, Stanbury T, Bennouna J
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.3537